OMCL Omnicell, Inc.

34.64USD+3.10%Mkt Cap: 1.58B $P/E: 41.24

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in …

Key Statistics

Company
Market Cap1.58B USD
Enterprise Value1.44B USD
Revenue (TTM)1.25B USD
Gross Profit503.44M USD
Net Income (TTM)2.05M USD
Revenue/Share27.49 USD
Last Price34.64 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees3.5K
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)41.24
P/E (Forward)16.08
PEG15.40
EV/EBITDA17.53
EV/Revenue1.16
P/S1.23
P/B1.19
EPS (TTM)0.84
EPS (Forward)2.09
52W Range
29.0622% of range55.00
52W High55.00 USD
52W Low29.06 USD
Profitability
Gross Margin42.49%
Oper. Margin5.91%
EBITDA Margin6.59%
Profit Margin0.17%
ROE0.17%
ROA0.10%
Growth
Revenue Growth7.50%
Earnings Growth333.30%
Cash Flow & Leverage
Operating CF127.30M USD
CapEx (TTM)57.93M USD
FCF Margin10.76%
FCF Yield8.49%
Net Debt-92.17M USD
Net Debt/EBITDA-1.12
Balance Sheet
Debt/Equity0.17
Current Ratio1.64
Quick Ratio1.19
Book Value/Sh28.32 USD
Cash/Share6.41 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)57.86 USD
Upside (mean)+67.0%
Target Range45.00 USD – 70.00 USD
45.00+67.0% to mean70.00
# Analysts7
Ownership
Shares Out.45.61M
Float44.38M
Insiders2.15%
Institutions108.18%
Short Interest
Short Ratio5.0d
Short % Float8.75%
Short % Out.7.22%
Shares Short3.29M
Short (prev mo.)3.37M
Technical
SMA 5035.24 (-1.7%)
SMA 20040.15 (-13.7%)
Beta0.97
S&P 52W Chg14.58%
Avg Vol (30d)581.85K
Avg Vol (10d)495.02K
Technical Indicators
RSI (14)51.0
MACD-0.6223
MACD Signal-0.9777
MACD Hist.+0.3554
BB Upper35.15 USD
BB Middle33.57 USD
BB Lower31.99 USD
BB Width9.42%
ATR (14)1.150 USD
Vol Ratio (20d)0.70x